pubrio
Alto Neuroscience

Alto Neuroscience

United States · Biotechnology

Pharmaceuticals

Biotechnology

Healthcare

Alto Neuroscience is redefining psychiatry by leveraging individuals' neurobiology to develop personalized and highly effective medicines, helping patients get better faster. Alto's Precision Psychiatry Platform™ measures biomarkers like EEG and wearable data, behavioral patterns, genetics, and other factors to match patients with the treatment they are most likely to respond to. Our approach matches the right patient with the right Alto drug based on AI-derived brain biomarkers, redefining psychiatry at a time when the world needs it most.

Company Insights
Company Overview

2019

Founded

Biotechnology

Industry

United States

Location

1,618,537

Ranking

81 employees

Size

Similar Companies
Similiar Companies

Get full access to view complete information

Frequently Asked Questions Regarding Alto Neuroscience

Start your journey today

Start with the platform — or start with a conversation

Use Pubrio on your own, or let our team help you with research, lead generation, or data integration.

Talk to Our Team
Start Journey Image
pubrio

Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.​

Call Center

85259256922

Our Location

15th Floor ADGM Square, UAE

Social Network

© Pubrio 2026